Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.12 -0.08 -40.00%
|
OTCQB:IOTCF
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
Probiotic Testing for Natural Health Products USP <64>
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL™ Silver
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
News
November 5, 2024
Innovotech Closes Over-subscribed Private Placement and Completes Acquisition of Keystone Labs
October 30, 2024
Innovotech Announces Update to Keystone Acquisition and Private Placement
October 21, 2024
Innovotech signs Definitive Agreement to Acquire Keystone Labs
September 30, 2024
Interim Financial Statements & MD&A for period ended 30 September 2024
September 11, 2024
Innovotech enters LOI to acquire Keystone
August 20, 2024
Q2-2024 Results
July 16, 2024
2024 Annual General and Special Meeting Results
June 30, 2024
Interim Financial Statements & MD&A for period ended 30 June 2024
June 18, 2024
InnovoSIL(TM)-1 Antimicrobial Silver Shown to Kill Medically Important Viruses
May 21, 2024
Q1-2024 Results
April 24, 2024
Innovotech Reports a Loss for Fiscal 2023
March 31, 2024
Interim Financial Statements & MD&A for period ended 31 March 2024
Page
1
Page
2
Page
3
Page
4
Page
5